Prognostic role of ultrasonography staging in patients with anal cancer
- PMID: 32864041
- PMCID: PMC7428798
- DOI: 10.4251/wjgo.v12.i7.732
Prognostic role of ultrasonography staging in patients with anal cancer
Abstract
Background: Carcinomas of the anal canal are staged according to the size and extent of the disease; however, we propose including a novel ultrasound (US) staging system, based on depth of tumor invasion. In this study the clinical American Joint Committee on Cancer (AJCC) staging guidelines and the US classificationss in patients with anal cancer were compared.
Aim: To evaluate the prognostic role of the US staging system in patients with anal cancer.
Methods: The data of 48 patients with anal canal squamous cells carcinoma, observed at our University Hospital between 2007 and 2017, who underwent pre-treatment assessment with pelvic magnetic resonance imaging (MRI), total body computed tomography (CT) scan and endoanal US were retrospectively reviewed. Anal canal tumors were clinically staged according to AJCC, determined by MRI by measurement of the longest tumor diameter, and CT scan. Endoanal US was performed with a high multi-frequency (9-16 MHz), 360° rotational mechanical probe; US classification was based on depth of tumor penetration through the anal wall, according to Giovannini's study. All patients were treated with definitive radiation combined with 5-fluorouracile and Mitomycin-C. After treatment patients were followed-up regularly.
Results: At baseline there were 30 and 32 T1-2, 18 and 16 T3-4, 31 and 19 N+ patients classified according to the clinical AJCC and US staging system respectively. After a mean follow-up of 98 months, 38 patients (79.1%) are alive and 28 (58.3%) are disease free. During follow up 20 patients (41.6%) experienced recurrences. After univariate analysis, American Society of Anesthesiologists (ASA) score (P = 0.00000001) and US staging (P = 0.009) were significantly related to disease-free survival (DFS). When overall survival and DFS functions were compared, a statistically significant difference was observed for DFS survival when the US staging was applied with respect to the clinical AJCC staging. By combining the 2 significant prognostic variables, namely the US staging with the ASA score, four risks groups with different prognoses were identified.
Conclusion: Our findings suggest that US staging may be superior to traditional clinical staging, since it is significantly associated with DFS in anal cancer patients.
Keywords: American Joint Committee on Cancer staging; Anal cancer; Disease-free survival; Prognosis; Staging; Ultrasonography staging.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: There are no conflicts of interest to report.
Figures





Similar articles
-
Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system.Dis Colon Rectum. 2002 Jan;45(1):16-22. doi: 10.1007/s10350-004-6108-1. Dis Colon Rectum. 2002. PMID: 11786758 Clinical Trial.
-
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.Cancer. 1999 Nov 1;86(9):1700-11. Cancer. 1999. PMID: 10547542
-
Comparison of Anal Versus Rectal Staging in the Prognostication of Rectal Squamous Cell Carcinoma: A Population-Based Analysis.Dis Colon Rectum. 2019 Mar;62(3):302-308. doi: 10.1097/DCR.0000000000001205. Dis Colon Rectum. 2019. PMID: 30398999
-
Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up.Eur Radiol. 2011 Apr;21(4):776-85. doi: 10.1007/s00330-010-1980-7. Epub 2010 Oct 3. Eur Radiol. 2011. PMID: 20890758 Review.
-
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.Cancer. 1999 Apr 15;85(8):1686-93. doi: 10.1002/(sici)1097-0142(19990415)85:8<1686::aid-cncr7>3.0.co;2-7. Cancer. 1999. PMID: 10223561 Review.
References
-
- Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975-2016. National Cancer Institute. Bethesda, MD, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Available from: https://seer.cancer.gov/csr/1975_2016/
-
- Morton M, Melnitchouk N, Bleday R. Squamous cell carcinoma of the anal canal. Curr Probl Cancer. 2018;42:486–492. - PubMed
-
- Welton ML, Steele SR, Goodman KA, Gunderson LL, Asare EA, Brierley JD, Compton CC, De Nardi P, Goldberg RM, Gress D, Washington MK, Jessup JM, Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. Chicago, IL: AJCC; 2017: 275.
-
- Tarantino D, Bernstein MA. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system. Dis Colon Rectum. 2002;45:16–22. - PubMed
-
- Giovannini M, Bardou VJ, Barclay R, Palazzo L, Roseau G, Helbert T, Burtin P, Bouché O, Pujol B, Favre O. Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy. 2001;33:231–236. - PubMed
LinkOut - more resources
Full Text Sources